The optimization of our lead GK activator 2a to 3-[(1S)-2-hydroxy-1-methylethoxy]-5-[4-(methylsulfonyl) phenoxy]-N-1,3-thiazol-2-ylbenzamide (6g), a potent GK activator with good oral availability, is described, including to uncouple the relationship between potency and hydrophobicity. Following oral administration, this compound exhibited robust glucose lowering in diabetic model rodents. (C) 2009 Elsevier Ltd. All rights reserved.
Trans-esterification as a means of halide esterification under neutral conditions
作者:W. M. Corbett、J. Kenner
DOI:10.1039/jr9530003572
日期:——
XADZHIBEKOV, S. I.;MAKSUDOV, N. X.;TULYAGANOV, S. R.;SULTANKULOV, A., DOKL. AN UZSSR, 1984, N 3, 37-38
作者:XADZHIBEKOV, S. I.、MAKSUDOV, N. X.、TULYAGANOV, S. R.、SULTANKULOV, A.